PuSH - Publikationsserver des Helmholtz Zentrums München

The role of hepatokines in NAFLD.

Cell Metab. 35, 236-252 (2023)
Verlagsversion Postprint DOI PMC
Open Access Green
Non-alcoholic fatty liver disease (NAFLD) is not only a consequence of insulin resistance, but it is also an important cause of insulin resistance and major non-communicable diseases (NCDs). The close relationship of NAFLD with visceral obesity obscures the role of fatty liver from visceral adiposity as the main pathomechanism of insulin resistance and NCDs. To overcome this limitation, in analogy to the concept of adipokines, in 2008 we introduced the term hepatokines to describe the role of fetuin-A in metabolism. Since then, several other hepatokines were tested for their effects on metabolism. Here we address the dysregulation of hepatokines in people with NAFLD. Then, we discuss pathophysiological mechanisms of cardiometabolic diseases specifically related to NAFLD by focusing on hepatokine-related organ crosstalk. Finally, we propose how the determination of major hepatokines and adipokines can be used for pathomechanism-based clustering of insulin resistance in NAFLD and visceral obesity to better implement precision medicine in clinical practice.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
29.000
5.096
38
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Hormone-binding Globulin; Fatty Liver-disease; Fetuin-a Levels; Alpha(2)-heremans-schmid Glycoprotein/fetuin-a; Incident Diabetes-mellitus; De-novo Lipogenesis; Insulin-resistance; Hepatic Steatosis; Selenoprotein P; Adipose-tissue
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 1550-4131
e-ISSN 1932-7420
Zeitschrift Cell Metabolism
Quellenangaben Band: 35, Heft: 2, Seiten: 236-252 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort 50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Begutachtungsstatus Peer reviewed
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502400-001
Förderungen National Institutes of Health
German Federal Ministry of Education and Research (BMBF)
Scopus ID 85147336851
PubMed ID 36754018
Erfassungsdatum 2023-02-11